Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis

doi:10.3748/wjg.v13.i34.4593

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3623)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

408

HTML

2607

Figures (1-4)

358

Tables (1-1)

250

Sum=3623

Sep 14, 2007 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Sep 14, 2007; 13(34): 4593-4597
Published online Sep 14, 2007. doi: 10.3748/wjg.v13.i34.4593

Full Size Figure Download Figure

Figure 1 Response to gemcitabine in pancreatic cancer cell lines. Dose-response curves for gemcitabine in PK-9 (A) and PANC-1 (B). These are representative gemcitabine-sensitive and -resistant cell lines, respectively. Each bar represent a standard deviation (SD).

Citation: Ishida M, Sunamura M, Furukawa T, Akada M, Fujimura H, Shibuya E, Egawa S, Unno M, Horii A. Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. World J Gastroenterol 2007; 13(34): 4593-4597
URL: https://www.wjgnet.com/1007-9327/full/v13/i34/4593.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i34.4593